Bausch + Lomb (NYSE:BLCO – Get Rating) and Warby Parker (NYSE:WRBY – Get Rating) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, risk, dividends, earnings, analyst recommendations, institutional ownership and profitability. Profitability This table compares Bausch + Lomb and Warby […]
Bausch + Lomb Co. (NYSE:BLCO – Get Rating)’s share price reached a new 52-week low during trading on Monday . The stock traded as low as $13.70 and last traded at $13.73, with a volume of 2165 shares. The stock had previously closed at $14.07. Several research firms have issued reports on BLCO. Guggenheim began […]
Bausch + Lomb (NYSE:BLCO – Get Rating) and STAAR Surgical (NASDAQ:STAA – Get Rating) are both mid-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, valuation, dividends, risk, profitability, analyst recommendations and institutional ownership. Profitability This table compares Bausch + Lomb and […]
Bausch + Lomb Co. (NYSE:BLCO – Get Rating) – Research analysts at Jefferies Financial Group decreased their Q2 2022 EPS estimates for Bausch + Lomb in a research report issued on Wednesday, June 8th. Jefferies Financial Group analyst Z. Weiner now expects that the company will earn $0.22 per share for the quarter, down from […]
Bausch + Lomb (NYSE:BLCO – Get Rating) and Cooper Companies (NYSE:COO – Get Rating) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, dividends, earnings, analyst recommendations, profitability, institutional ownership and risk. Institutional & Insider Ownership 98.4% of Cooper Companies shares […]